12:00 AM
 | 
May 08, 2000
 |  BC Week In Review  |  Clinical News  |  Regulatory

Paxil paroxetine selective serotonin reuptake inhibitor regulatory update

SB submitted to the FDA an sNDA for Paxil to treat generalized anxiety disorder....

Read the full 49 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >